GlassScriptPhysician profile
Danielle R Pender
NPI 1326815622
$1,924.67
in general payments reported to CMS, 2019-2025
19 companies · $1,057 in 2025
The $1,057 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $867 · 2025: $1,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,924.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $291.72 | 2025 | Symplicity G3 |
| Novartis Pharmaceuticals Corporation | $240.96 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $206.39 | 2024-2025 | Lokelma, Wainua, Farxiga |
| Daiichi Sankyo INC. | $198.97 | 2024-2025 | Injectafer |
| Lexicon Pharmaceuticals, INC. | $139.99 | 2024 | Inpefa |
| Merck Sharp & Dohme LLC | $109.47 | 2024-2025 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $101.90 | 2025 | |
| Amgen INC. | $100.14 | 2024-2025 | Repatha, Repatha |
| Pfizer INC. | $94.02 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $87.28 | 2024-2025 | Opsumit, Uptravi |
| Kiniksa Pharmaceuticals International, Plc | $80.29 | 2024 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $72.26 | 2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $47.59 | 2025 | Camzyos |
| Novo Nordisk INC | $47.35 | 2024 | Rybelsus, Ozempic |
| Cvrx, INC. | $29.99 | 2024 | Barostim Neo System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $29.65 | 2024 | Amvuttra |
| Atricure, INC. | $16.00 | 2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Scpharmaceuticals INC. | $15.92 | 2024 | |
| Convatec INC. | $14.78 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Pender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.